New data from a study on Novo Nordisk’s weight-loss drug, amycretin, has shown positive results. Participants in the study who received the highest dose of the drug lost an average of 22 percent of their body weight after 36 weeks.After the study was published, Novo Nordisk’s stock value rose by about 10 percent on Friday […]